Your browser doesn't support javascript.
loading
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis.
Apolo, Andrea B; Ellerton, John A; Infante, Jeffrey R; Agrawal, Manish; Gordon, Michael S; Aljumaily, Raid; Gourdin, Theodore; Dirix, Luc; Lee, Keun-Wook; Taylor, Matthew H; Schöffski, Patrick; Wang, Ding; Ravaud, Alain; Manitz, Juliane; Pennock, Gregory; Ruisi, Mary; Gulley, James L; Patel, Manish R.
Afiliación
  • Apolo AB; Hematology Oncology, Oregon Health & Science University, Portland, Oregon, USA andrea.apolo@nih.gov.
  • Ellerton JA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Infante JR; Nevada Cancer Research Foundation, Las Vegas, Nevada, USA.
  • Agrawal M; Sarah Cannon Research Institute, Nashville, Tennessee, USA.
  • Gordon MS; Associates in Oncology, Rockville, Maryland, USA.
  • Aljumaily R; Nevada Cancer Research Foundation, Las Vegas, Nevada, USA.
  • Gourdin T; HonorHealth Research Institute, Scottsdale, Arizona, USA.
  • Dirix L; Hematology/Oncology, The University of Oklahoma Stephenson Cancer Center, Oklahoma City, Oklahoma, USA.
  • Lee KW; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Taylor MH; Department of Medical Oncology, Sint-Augustinus Hospital Oncology Centre, Antwerp, Belgium.
  • Schöffski P; Department of Internal Medicine, Seoul National University College of Medicine, Seongnam, Republic of Korea.
  • Wang D; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Ravaud A; Laboratory of Experimental Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium.
  • Manitz J; Henry Ford Cancer Institute, Detroit, Michigan, USA.
  • Pennock G; Department of Medical Oncology, Bordeaux University Hospital, Bordeaux, France.
  • Ruisi M; EMD Serono Research & Development Institute, Inc, Billerica, Massachusetts, USA; a business of Merck KGaA, Darmstadt, Germany.
  • Gulley JL; EMD Serono, Inc, Rockland, Massachusetts, USA; a business of Merck KGaA, Darmstadt, Germany.
  • Patel MR; EMD Serono Research & Development Institute, Inc, Billerica, Massachusetts, USA; a business of Merck KGaA, Darmstadt, Germany.
J Immunother Cancer ; 8(2)2020 10.
Article en En | MEDLINE | ID: mdl-33037118
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Platino (Metal) / Carcinoma de Células Transicionales / Protocolos de Quimioterapia Combinada Antineoplásica / Anticuerpos Monoclonales Humanizados / Antígeno B7-H1 Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Platino (Metal) / Carcinoma de Células Transicionales / Protocolos de Quimioterapia Combinada Antineoplásica / Anticuerpos Monoclonales Humanizados / Antígeno B7-H1 Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article